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Abstract 
Background and purpose 
Silent ischemic events are known to occur during diagnostic and interventional endovascular 
procedures between 10 and 69%. The occurrence of silent and symptomatic ischemic events in 
the surgically treated population is not known, although atherosclerotic changes of intracranial 
vessels or within the aneurysms wall or neck area are seen often during surgery.  
Methods: 
Patients with unruptured and ruptured intracranial aneurysms treated by microsurgical clipping 
were prospectively evaluated with MRI using DWI sequences before and within 24 hours after 
surgery. Patients were evaluated clinically before and after surgery. During surgery the overall 
and maximal time of temporary occlusion, as well as the total number of temporary and finally 
applied clips were noted.  DW images were analyzed with determination and characterization of 
DW imaging abnormalities. 
Results 
Thirty-six patients with 51 aneurysms were included. One symptomatic and 5 silent ischemic 
lesions were found in 5 patients. This represents a risk of silent ischemia of 9.8% per aneurysm 
and a risk of symptomatic stroke of 2%. Most significant risk factor in increasing order was: age 
(p<0.05), presence of thrombus (p<0.05), number of final clips applied (p<0.05), number of 
temporary clips used (p<0.01), total time of temporary clip occlusion (p<0.001) and maximal 
time of temporary occlusion (p<0.001). 
Conclusions 
The risk of silent ischemic events during microsurgical clipping of aneurysms seems to be lower 
than is encountered with endovascular procedures. Microsurgical clipping of aneurysms is safe 
and should continue to be strongly considered as a primary treatment option. 
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Introduction 
Silent ischemic events are known to occur during diagnostic and interventional 
endovascular procedures.1 However, it has become clear that silent ischemic events in the deep 
white matter are not really silent.2 While the patient’s routine neurological exam may be normal, 
an in depth evaluation with neuropsychological and cognitive testings is likely to reveal deficits 
that are otherwise not easy to detect. 
The recently published results of the ISAT study 3 led to a significant increase in the 
number of endovascular procedures performed for the treatment of intracranial aneurysms. 
Although the study itself included only patients with subarachnoid hemorrhage and 93% of the 
patients included in the study had small-sized aneurysms, endovascular coiling for aneurysms is 
performed for the treatment of unruptured aneurysms as well as large and complex types of 
aneurysms. Several previously reported studies indicate that ischemic events, both silent and 
symptomatic, are frequent during endovascular coiling of intracranial aneurysms and more 
frequently when treating more complex aneurysms including more involved steps such as, 
balloon assisted remodeling.1, 4-11 This fact continues to be true even after the use of 
anticoagulants during the procedures.5, 7-11 
The occurrence of silent ischemic events in patients with aneurysms treated with 
microsurgical clipping is not known. In addition, it is our belief that there is a good number of 
aneurysms that are better served with microsurgical clipping performed by an experienced 
cerebrovascular team. Based on this, we performed this study to analyze the risk of symptomatic 
and silent ischemia during the microsurgical clipping of intracranial aneurysms using MR 
imaging. We also looked at the available literature as it relates to the occurrence of ischemia 
during endovascular coiling of aneurysms and tried to compare and contrast the results.1, 4-6, 8-12 
Methods 
All patients with ruptured and unruptured intracranial aneurysms admitted between 
December 2005 and March 2007 to our institution were prospectively evaluated with MRI before 
 4
and within 24h after microsurgical clipping of the aneurysm performed by the senior author 
(AFK). The following patients were excluded for this study: patients with cerebral angiography 
after the initial MRI study, patients who were not cooperative or had contraindications for MRI 
due to their medical condition, patients in whom emergency operation did not allow MRI study 
prior to surgery (such as patients with hematomas), patients in whom the aneurysm was treated 
with a bypass. For radiological evaluation we used the following MRI sequences: T1, T2, FLAIR, 
Diffusion and Perfusion. All MRI studies were evaluated by one neuroradiologist (E.E.) for 
detection of signs of ischemia. 
In all patients the following parameters were collected: Age, sex, presence of 
subarachnoid hemorrhage (SAH), day after SAH, grading according to the Yasargil grading score 
(Table 1) 13, presence of vascular risk factors like arterial hypertension, smoking habit, history of 
prior cerebral ischemia. The aneurysm number, their sizes (small <7mm, medium 7-12mm, large 
13-25mm, giant >25mm) and location was noted. The patients were clinically evaluated before 
and after surgery to detect any new neurological deficits. 
During the whole surgical procedure patients were kept normovolemic, with a mean 
arterial pressure between 80-105mm Hg. No burst suppression is performed nor was Mannitol or 
other medications used for brain protection during the clipping process. The microsurgical 
technique included either a pterional or pretemporal craniotomy with wide opening of the basal 
cisterns, opening of the proximal sylvian fissure and anterior sylvian fossa. This allowed 
quantifying the extent of atherosclerotic disease of the intracranial vessels by the view through 
the microscope, using a grading system shown in Table 2. The presence of an intraaneurysmal 
thrombus and of peri- or intraaneurysmal atherosclerotic plaques was noted. The number of 
temporary clips applied was counted and the maximal and total time of temporary occlusion 
recorded. Also the total number of final clips applied was counted, including all the final clips 
that were put, removed or readjusted (only counted if the clip was completely opened) during the 
clipping process. 
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Statistical analysis was performed to determinate individual risk factors for ischemia 
using the SPSS software. Ordinal variables were reencoded numerically and patients groups were 
compared by univariate analysis of variance. 
Results 
Thirty-six patients (4male / 32 female, mean age 54.4y) with 51 aneurysms were included 
in the study. Five patients (14%) had a history of cerebrovascular ischemia, 22 (61%) were 
known for arterial hypertension and 25 (69%) were smokers. According to the Yasargil grading 
system, 25 (69.4%) patients were classified as grade 0, 2 (5.6%) as grade 1, 6 (16.7%) as grade 2, 
2 (5.6%) as grade 3 and 1 (2.8%) as grade 4, meaning also that 11 patients (31%) presented with 
subarachnoid hemorrhage. The sizes of the aneurysms were as followed: small 23 (45.1%), 
medium 17 (33.3%), large 8 (15.7%) and giant 3 (5.9%). The distribution of the aneurysms 
according to their location is shown in Table 3. In 21 patients (58.3%) 1 aneurysm was clipped, in 
5 patients (13.9%) 2 aneurysms, in 3 patients (8.3%) 3 aneurysms and in 1 patient (2.8%) 5 
aneurysms. The grading of atherosclerotic changes according to table 2 was grad 0 (39.2%), 
grade I (39.2%), grade II (9.8%) and grade III (11.8%). Twenty aneurysms (39.2%) showed 
atherosclerotic plaques within the dome or close to the base and 6 aneurysms (11.8%) were 
partially thrombosed. 
Radiological results 
In 51 clipped aneurysms 6 ischemic lesions were found in 5 patients with either large or 
giant aneurysms. Only 1 of 6 lesions was symptomatic, and 5 were silent. Three of these 5 
patients had a subarachnoid hemorrhage. Two patients had a basilar tip, one a partially 
thrombosed anterior communicating aneurysm, one a partially thrombosed superior cerebellar 
aneurysm, and one a large and complex middle cerebral artery bifurcation aneurysm. The 
distribution of the ischemic lesions was confined to the vascular territory of perforating arteries in 
50% of cases, two of them with basilar artery and one with middle cerebral artery aneurysm. 
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These findings represent a risk of silent ischemia of 9.8% per aneurysm, a risk of symptomatic 
stroke of 2%. 
Statistical analysis 
Univariant analysis showed statistical significance for several parameters regarding the 
risk of stroke. Most significant variable in increasing order was: age (p<0.05), presence of 
thrombus (p<0.05), number of final clips applied (p<0.05), number of temporary clips used 
(p<0.01), total time of temporary clip occlusion (p<0.001) and maximal time of temporary 
occlusion (p<0.001). Other factors did not reach statistical significance like the size of the 
aneurysm (p=0.64) and the grade of atherosclerotic disease (p=0.77). Detailed analysis is shown 
in Table 4. 
Discussion 
The ISAT study has created a new paradigm in the treatment of intracranial aneurysms.3 
Although the study was restricted to patients who suffered subarachnoid hemorrhage and 93% of 
the patients included in the study were small aneurysms, the trend in many centers is to refer 
every aneurysm to endovascular therapy as the primary treatment modality. In many instances 
this is being done irrespective of the aneurysm location, size, dimensions and the lack of 
durability of the treatment. The occurrence of ischemic events both silent and symptomatic during 
diagnostic and therapeutic endovascular procedures is not very low and cannot be ignored. 1 
Soeda, et al looked at the thromboembolic events associated with Guglielmi Detachable Coil 
(GDC) embolization of asymptomatic cerebral aneurysms.11 They evaluated 66 consecutive cases 
with the use of diffusion weighted MR imaging. Forty-nine percent of the patients were treated 
with balloon-assisted technique. Diffusion weighted images were performed in 66 patients at 2-5 
days after embolization. Hyperintense lesions occurred in 40 patients (61%) and sixteen patients 
(40%) had neurological deteriorations.  They did mention that hyperintense lesions were more 
frequently seen in wide neck (73%) or large (100%) aneurysms when balloon-assisted techniques 
were used during the procedure and confirmed by multivariant analysis that the use of this 
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technique resulted in a significant association with the occurrence of ischemic changes. From 
their study they concluded that thromboembolic events related to GDC embolization are common 
and more so in wide-neck and/or large aneurysms especially when the balloon-assisted technique 
is utilized. In another study Grunwald, et al evaluated the frequency and causes of 
thromboembolic events associated with endovascular embolization with symptomatic 
aneurysms.8 They studied the occurrence of hyperintense lesions on diffusion weighted images in 
50 patients. The aneurysm sizes varied between 3 and 15 mm. New hyperintense lesions occurred 
in 21 of the 50 patients (42%) on diffusion weighted imaging studies. In 33% there was more than 
one lesion and in 19% their lesions were 2-10 mm in size. One patient had a lesion more than 10 
mm in size. This high rate of thromboembolic events occurred in spite the use of anticoagulation 
with heparin. In another study by Sakai et al, they evaluated 137 patients who received 154 
neurointerventional procedures and studied the diffusion-weighted images before and within 5 
days after treatment.14 Diffusion-weighted imaging detected procedure-related lesions in 83 of 
154 procedures (53.9%). Only 36 demonstrated no new neurological symptoms during and/or 
after the procedure. In 46.1% there were no lesions. What’s interesting in the study is the 
distribution of the ischemia suggested that ischemic events occur not only due to embolic 
phenomenon but also due to hypoperfusion resulting in ischemia in watershed areas. 
In view of the high rate of silent ischemia (10 to 69%) that occurs with endovascular 
procedures 1, 4- 6, 8- 12 and the risk of symptomatic ischemia in 3% to 4% 7, 15, we felt it important to 
evaluate the occurrence of such events in patients treated with microsurgical clipping techniques. 
We found no studies that tried to look into the rate of occurrence of such ischemic events based 
on MRI findings. Our findings with a rate of 9.8% for silent ischemia and of 2% for symptomatic 
stroke suggest that the occurrence of ischemia during microsurgical clipping of aneurysms is low, 
especially when the complexity of the treated aneurysms is taken into consideration since basilar 
apex aneurysms (23.5%) and paraclinoid aneurysms (19.6%) comprised 43% of the total number 
of aneurysms treated. Also considering that 21% of the aneurysms were large or giant. However, 
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our referral pattern may be a reflection of the future referral pattern of aneurysms in general. This 
is because the aneurysms being referred for microsurgical clipping are becoming more complex 
because they either failed attempts at their endovascular treatment or regrown and/or recanalized 
after previous coiling procedures. This will lead us to conclude that if the majority of aneurysms 
get referred for microsurgical clipping to start with, the aneurysm mix may become less complex 
and lead to lower rate of ischemia. 
It has previously been suggested that the use of temporary clipping during microsurgery 
of aneurysms leads to ischemic events.16, 17, 18, 19, 20, 21 The duration of temporary clipping was 
found to correlate with the increased occurrence of ischemic events.16, 18, 20 This is why in our 
practice we generally use short periods of temporary clip applications (<180 seconds). If the need 
arises for a longer temporary clip application time, we then rely on the electrophysiological 
changes that may occur during intraoperative monitoring. We routinely use intraoperative 
somatosensory evoked potentials and electroencephalography (EEG). More recently we have 
utilized motor evoked potentials as well. Intraoperative monitoring in our experience has proven 
to be of significant value in guiding the temporary clip application process. We generally avoid 
using cerebral protection agents because of their questionable benefit and in order to avoid false 
sense of security which may lead to prolonging the temporary clip application time. It also 
interferes with the intra operative electrophysiologic monitoring. 
In our statistical analysis we found out that multiple uses of temporary clips as well as the 
longer period of temporary clip applications influence the occurrence of both silent and 
symptomatic ischemia. However we have to keep in mind that one longer clip application 
influences the total occlusion time. Repeated clip applications, not only of the temporary clips but 
also the final clips, increased the risk of ischemic changes. This may be due to the fact that a 
higher number of permanent clips are usually needed for more complex aneurysms that usually 
necessitate more surgical manipulation. This may have led to formation of new microthrombi or 
detachment of already existing thrombi.  In our study the presence of intra-aneurysmal thrombus 
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increases the risk of ischemic events, a factor that should be considered in such cases. In our 
practice, when possible, we preoperatively start patients with suspected or confirmed intra-
aneurysmal clot or thrombus on 81 mg aspirin tablets. 
Even though the age of the patients seems to correlate with the higher occurrence of 
ischemic, both silent and symptomatic, events in our patients did not seem to be related to the 
extent of atherosclerotic disease found involving the blood vessels. This may be related to the 
lack of adequate collateral flow in these patients. 
Our study is one of the few if not the first study that looks at the occurrence of both silent 
and symptomatic ischemic events during microsurgical treatment of aneurysms based on MRI 
criteria. The occurrence of both symptomatic and asymptomatic ischemia during microsurgical 
clipping of aneurysms seems to be much less commonly encountered than what has been reported 
for endovascular procedures, in spite of the later taking advantage of full anticoagulation. These 
findings and the better durability achieved of microsurgical clipping of aneurysms should be 
factored into the decision making process of what would be the best treatment option for a 
particular aneurysm. 
Conclusion 
The risk of silent ischemic events during microsurgical clipping of aneurysms seems to 
be much lower than is encountered with endovascular procedures, especially in view of the higher 
complexity of aneurysms in our cohort. The risk of symptomatic and silent ischemic events is low, 
and it tends to increase with the increase in aneurysm complexity especially in partially 
thrombosed aneurysms. Microsurgical clipping of aneurysms is safe, durable and should continue 
to be strongly considered as a primary treatment option. 
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Table 1 
 
Classification according to Yaşargil grading system 13 
 
Grade and condition Neurological subgroup deficit/cranial 
neuropathy or hemisyndrome 
0 Unruptured 
    a Asymptomatic  
    b Symptomatic, giant 
 
- 
+ 
1 Subarachnoid hemorrhage 
    a No deficits 
    b Minimal deficits, e.g., cranial neuropathy 
 
- 
+ 
2 Subarachnoid hemorrhage 
    a Headache and meningismus 
    b Minimal deficits 
 
- 
+ 
3 Subarachnoid hemorrhage 
    a Lethargic, confused, combative 
    b With hemisyndrome 
 
- 
+ 
4 Subarachnoid hemorrhage 
    Semicomatose, responds to pain but not voice 
 
5 Subarachnoid hemorrhage 
    Comatose, no reaction, failing vital signs 
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Table 2 
Degree of Atherosclerotic disease  
Grade Extent of atherosclerotic plaques 
0 No plaques 
I Patchy plaques 
II More plaques than normal vessel 
III Continuous plaques 
 
 
 
 
 
 
 
 
Table 3 
Distribution of 51 aneurysms according to their location  
Location of aneurysms Numbers (%) 
Internal carotid artery (supraclinoid segment) 5 (9.8) 
Internal carotid artery (paraclinoid segment) 10 (19.6) 
Internal carotid artery (intracavernous segment) 1 (2) 
Middle cerebral artery (M1 segment) 3 (5.9) 
Middle cerebral artery (Bifurcation) 12 (23.5) 
Anterior communicating artery 8 (15.7) 
Basilar artery (TIP & origin of superior cerebellar artery) 12 (23.5) 
Total 51 (100) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 15
Table 4 
Variables used for univaraint analysis using SPSS software 
Variables Numbers (%) p-value 
Mean Age (yrs) 54.4 ± 10.96 0.005 
Sex (male/female) 4 (11) /32 (89) 0.565 
SAH (yes/no) 11 (31) / 26 (69) 0.152 
Arterial Hypertension 
(yes/no) 
22 (61) / 14 (39) 0.119 
Smoker (yes/no) 25 (69) / 11 (31) 0.254 
History of CVI (yes/no) 5 (14) / 31 (86) 0.254 
Aneurysm location See table 2 0.514 
Mean number of Aneurysms 1.4 ± 0.87 0.872 
Aneurysms size (s/m/l/g) 23 (45.1) / 17 (33.3) / 8 (15.7) / 3 (5.9%) 0.064 
Grade of CVD (0/1/2/3) 20 (39.2) / 20 (39.2) / 5 (9.8) / 6 (11.8) 0.077 
Presence of plaques (yes/no) 20 (39) / 31 (61) 0.364 
Presence of thrombus 
(yes/no) 
6 (12) / 45 (88) 0.04 
Mean Number of temporary 
clips 
3.8 ± 4.08 0.01 
Mean total time of 
temporary occlusion (sec) 
585.4 ± 858.4 <0.001 
Mean maximal time of 
temporary occlusion (sec) 
185 ± 277 <0.001 
Mean Number of final clips 4.7 ± 3.7 0.16 
 
 
